Cognitive impairment in a population-based study of patients with multiple sclerosis: Differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis

European Journal of Neurology

Volumn 23, Issue 2, 2016, Pages 282-289

  Planche, V ^a   Gibelin, M ^b   Cregut, D ^a   Pereira, B ^a   Clavelou, P ^a,b,c  

^a SERVICE DE RHUMATOLOGIE   (France)

^b Réseau Neuro SEP Auvergne   (France)

^c Université d'Auvergne ^*  (France)

Author keywords

Cognitive impairment; Multiple sclerosis; Neuropsychology; Population based

Indexed keywords

ADULT; AGED; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEPTH PERCEPTION; DISEASE DURATION; EPISODIC MEMORY; EXECUTIVE FUNCTION; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; WORKING MEMORY; COGNITION DISORDERS; COMPARATIVE STUDY; COMPLICATION; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RETROSPECTIVE STUDIES;

EID: 84956576994     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12715     Document Type: Article

References (33)

1. Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008; 7: 1139-1151.
2. Gaudino EA, Chiaravalloti ND, DeLuca J, Diamond BJ. A comparison of memory performance in relapsing-remitting, primary progressive and secondary progressive, multiple sclerosis. Neuropsychiatry Neuropsychol Behav Neurol 2001; 14: 32-44.
3. Comi G, Filippi M, Martinelli V, et al. Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. J Neurol Sci 1995; 132: 222-227.
4. Huijbregts SCJ, Kalkers NF, De Sonneville LMJ, et al. Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS. Neurology 2004; 63: 335-339.
5. Ruet A, Deloire M, Charré-Morin J, et al. Cognitive impairment differs between primary progressive and relapsing-remitting MS. Neurology 2013; 80: 1501-1508.
6. Potagas C, Giogkaraki E, Koutsis G, et al. Cognitive impairment in different MS subtypes and clinically isolated syndromes. J Neurol Sci 2008; 267: 100-106.
7. Denney DR, Sworowski LA, Lynch SG. Cognitive impairment in three subtypes of multiple sclerosis. Arch Clin Neuropsychol 2005; 20: 967-981.
8. Wachowius U, Talley M, Silver N, et al. Cognitive impairment in primary and secondary progressive multiple sclerosis. J Clin Exp Neuropsychol 2005; 27: 65-77.
9. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
10. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302.
11. Smith A. Symbol Digit Modalities Test (SDMT). Los Angeles: Western Psychological Services, 1982.
12. Sheridan LK, Fitzgerald HE, Adams KM, et al. Normative Symbol Digit Modalities Test performance in a community-based sample. Arch Clin Neuropsychol 2006; 21: 23-28.
13. Wechsler D. Wechsler Adult Intelligence Scale, 3rd edn. San Antonio: Psychological Corporation, 1997.
14. Grober E, Buschke H. Genuine memory deficits in dementia. Dev Neuropsychol 1987; 3: 13-36.
15. Van der Linden M. L'évaluation des troubles de la mémoire, présentation de quatre tests de mémoire épisodique (avec leur étalonnage). Marseille: Solal, 2004.
16. Grégoire J, Van der Linden M. Effect of age on forward and backward digit spans. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 1997; 4: 140-149.
17. Golden CJ. Stroop Color and Word Test: A Manual for Clinical and Experimental Uses. Chicago: Skoelting, 1978.
18. Godefroy O. Fonctions exécutives et pathologies neurologiques et psychiatriques: evaluation en pratique clinique. Marseille: Solal, 2008.
19. Heaton RK, Chelune GJ, Talley JL, et al. A Manual for the Winsconsin Card Sorting Test. Odessa, TX: Psychological Assessment Resources, 1981.
20. Tombaugh TN. Trail Making Test A and B: normative data stratified by age and education. Arch Clin Neuropsychol 2004; 19: 203-214.
21. Cardebat D, Doyon B, Puel M, et al. Formal and semantic lexical evocation in normal subjects. Performance and dynamics of production as a function of sex, age and educational level. Acta Neurol Belg 1990; 90: 207-217.
22. Deloche G, Hannequin D. Test de dénomination orale de 80 images. Paris: ECPA, 1997.
23. Dubois B, Slachevsky A, Litvan I, et al. The FAB: a Frontal Assessment Battery at bedside. Neurology 2000; 55: 1621-1626.
24. Austin P. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 2011; 46: 399-424.
25. Insee. Populations légales 2010 des région. www.insee.fr/fr/ppp/bases-de-donnees/recensement/populations-legales (accessed 09/01/2013)
26. Fromont A, Binquet C, Sauleau EA, et al. Geographic variations of multiple sclerosis in France. Brain 2010; 133: 1889-1899.
27. Borghi M, Cavallo M, Carletto S, et al. Presence and significant determinants of cognitive impairment in a large sample of patients with multiple sclerosis. PLoS One 2013; 8: e69820.
28. Beatty WW, Goodkin DE, Hertsgaard D, et al. Clinical and demographic predictors of cognitive performance in multiple sclerosis. Do diagnostic type, disease duration, and disability matter? Arch Neurol 1990; 47: 305-308.
29. Lynch SG, Parmenter BA, Denney DR. The association between cognitive impairment and physical disability in multiple sclerosis. Mult Scler 2005; 11: 469-476.
30. Sumowski JF, Rocca MA, Leavitt VM, et al. Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS. Neurology 2014; 82: 1776-1783.
31. Benedict RH, Zivadinov R. Risk factors for and management of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol 2011; 7: 332-342.
32. Bol Y, Duits AA, Hupperts RM, et al. The impact of fatigue on cognitive functioning in patients with multiple sclerosis. Clin Rehabil 2010; 24: 854-862.
33. Feinstein A. Multiple sclerosis and depression. Mult Scler 2011; 17: 1276-1281.